Somatic missense mutations in the gene encoding isocitrate dehydrogenase 1 (IDH1) or IDH2 are frequently identified in various malignancies including gliomas, acute myeloid leukemia, cholangiocarcinoma, chondrosarcoma and sporadically in various other cancer types [1–8]. Here, IDH1 is linked to central nervous system cancer.